About Swedish Pharma AB

Swedish Pharma AB is a privately owned Swedish company established in 2007. Our focus is on transdermal drug delivery using a novel bioadhesive patch technology (patent pending). The company is developing proprietary products using the unique properties of our patch.

Swedish Pharma AB will discuss licensing of its technology and can assist interested companies with compounding, optimization and even molecular design of molecules for improvement of drug delivery. Our company can assist in synthesis, patenting, and trials of new compounds.

Our patch technology has been tested in clinical trials and our capacity for molecular design has resulted in a completely new group of substances (patent pending) for treatment of skin cancer.

Several Swedish Institutions financially support our company. We collaborate with several companies and institutions both in Sweden and internationally.

We firmly believe that our business is based on a solid and unique technology and can be used for a large variety of products.